This was originally published on Global Health TV on June 28, 2016.
For some time, huge
disparities between global health spending and the global disease burden have
raised concerns that this funding was not being allocated based on the evidence.
That is, money was not always going where the disease burden was greatest.
The Institute for Health
Metrics and Evaluation (IHME) has pointed out that the disparities are most
extreme in HIV/AIDS on the high end and non-communicable diseases (NCDs) on the
low end.
As the toll from communicable
diseases like AIDS and malaria decline and people live long enough to get NCDs,
we need to invest more in fighting NCDs (also called “chronic diseases”) and
reduce these glaring disparities between global health spending and disease
burden. Countries like Botswana, Eritrea, Kenya Malawi, Mozambique, Rwanda,
South Africa, Swaziland, Tanzania, Uganda, Zambia and Zambia — all countries that
increased their treatment coverage by more than 25% between 2010 and 2015, according to UNAIDS — now have to pivot to NCDs without taking their eyes off of HIV.
Kenya is an excellent case in
point.


